Cite
Xing Y, Guo W, Wu M, et al. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo. Cancer Lett. 2022;529:100-111doi: 10.1016/j.canlet.2021.12.035.
Xing, Y., Guo, W., Wu, M., Xie, J., Huang, D., Hu, P., Zhou, M., Zhang, L., Zhang, Q., Wang, P., Wang, X., Wang, G., Wu, H., Zhou, C., Chen, Y., Liu, M., Yi, Z., & Sun, Z. (2022). An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo. Cancer letters, 529100-111. https://doi.org/10.1016/j.canlet.2021.12.035
Xing, Yajing, et al. "An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo." Cancer letters vol. 529 (2022): 100-111. doi: https://doi.org/10.1016/j.canlet.2021.12.035
Xing Y, Guo W, Wu M, Xie J, Huang D, Hu P, Zhou M, Zhang L, Zhang Q, Wang P, Wang X, Wang G, Wu H, Zhou C, Chen Y, Liu M, Yi Z, Sun Z. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo. Cancer Lett. 2022 Jan 04;529:100-111. doi: 10.1016/j.canlet.2021.12.035. Epub 2022 Jan 04. PMID: 34990752.
Copy
Download .nbib